[Role of tractography in stereotactic radiosurgery and brain stereotactic radiotherapy].
Intérêt de la tractographie pour la radiochirurgie et la radiothérapie stéréotaxique cérébrale.
Arcuate fasciculus
Brain
Cerveau
DTI
Faisceau arqué
Faisceau pyramidal
Optic radiation
Pyramidal tract
Radiations optiques
Radiochirurgie
Radiosurgery
Radiothérapie stéréotaxique
Stereotactic radiotherapy
Tractographie
Tractography
Journal
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
ISSN: 1769-6658
Titre abrégé: Cancer Radiother
Pays: France
ID NLM: 9711272
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
received:
22
07
2021
revised:
09
11
2021
accepted:
14
12
2021
pubmed:
8
3
2022
medline:
17
8
2022
entrez:
7
3
2022
Statut:
ppublish
Résumé
Hypofractionated stereotactic radiotherapy and stereotactic radiosurgery are major therapeutic weapons in the brain, whether for tumor, vascular or functional treatments. They tend increasingly to democratize and to become standard treatments. However, human brain anatomy is very complex and not limited to the currently described organs at risk. Diffusion tensor imaging (DTI) tractography is a simple tool that enables to identify reproducibly big white matter fiber tracts. Not only does tractography allow a redefinition of organs at risk in the brain, but it would also allow the identification of new targets, such as the ventral intermediate nucleus (Vim) within the thalamus for treatment of movement disorders. We present here a review of the role of tractography and the anatomy, function and currently described dose-effect relationships of white matter fiber tracts with a major functional impact: the pyramidal tract for motor ability, the optic radiation for vision and the arcuate fasciculus for language.
Identifiants
pubmed: 35249816
pii: S1278-3218(22)00037-3
doi: 10.1016/j.canrad.2021.12.007
pii:
doi:
Types de publication
Journal Article
Review
Langues
fre
Sous-ensembles de citation
IM
Pagination
736-741Informations de copyright
Copyright © 2022 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.